Back
PTC Therapeutics Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PTCT
PTC Therapeutics
Last Price:
$55.01
Seasonality Move:
12.15%
7 Day Trial
ALL ACCESS PASS
$
7
Google closes secret $20B deal with Apple to become iPhone's default search engine
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.PTC Therapeutics Stock Forecast
-
Over the next 52 weeks, PTC Therapeutics has on average historically risen by 39.8% based on the past 11 years of stock performance.
-
PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
-
Is PTC Therapeutics Stock Undervalued?The current PTC Therapeutics [PTCT] share price is $56.27. The Score for PTCT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
PTCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will PTC Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, PTC Therapeutics has on average historically risen by 39.8% based on the past 11 years of stock performance.
PTC Therapeutics Stock Rating
Buy
51
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics overpriced?
-
PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
PTC Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com
52-Week Data
52-Week High:
58.38
52-Week Low:
24.00
Prediction Charts
Market Cap:
4.4B
Price in USD:
56.27
Volume:
1.2M
Beta:
0.82
Technical Analysis
SMA50:
49.86
SMA100:
47.28
SMA200:
41.03
52-Wk Change:
94.98%
Stock Predictions
-
Is PTC Therapeutics stock public?Yes, PTC Therapeutics is a publicly traded company.
-
What is the PTC Therapeutics stock quote today?The PTC Therapeutics stock price is 56.27 USD today.
-
How to buy PTC Therapeutics stock online?You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-5 | 51.66 | 51.93 | 52.47 | 50.93 |
| Mar-6 | 51.28 | 52.80 | 52.83 | 50.29 |
| Mar-7 | 52.92 | 52.59 | 53.79 | 51.59 |
| Mar-11 | 53.12 | 52.59 | 53.19 | 50.65 |
| Mar-12 | 53.00 | 53.61 | 53.76 | 52.26 |
| Mar-13 | 52.89 | 52.76 | 54.65 | 51.93 |
| Mar-14 | 53.50 | 54.50 | 55.65 | 53.09 |
| Mar-17 | 54.17 | 57.17 | 58.38 | 54.06 |
| Mar-18 | 56.54 | 55.47 | 57.20 | 55.11 |
| Mar-19 | 55.09 | 56.98 | 57.42 | 55.00 |
| Mar-20 | 56.40 | 56.63 | 57.56 | 56.23 |
| Mar-21 | 56.25 | 57.14 | 57.34 | 55.73 |
| Mar-24 | 57.97 | 57.03 | 57.97 | 56.14 |
| Mar-25 | 56.88 | 56.27 | 56.95 | 55.57 |
PTC Therapeutics Earnings
PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
PTC Therapeutics Forecast Revenue Growth
PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $1.60 per share.
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.